Aktis Oncology, Inc.
AKTS
$25.00
$0.281.13%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | |||
|---|---|---|---|---|---|
| Net Income | -33.58% | -22.29% | -25.56% | ||
| Total Depreciation and Amortization | 59.24% | 34.71% | 57.60% | ||
| Total Amortization of Deferred Charges | -- | -- | -- | ||
| Total Other Non-Cash Items | 983.66% | 502.75% | 163.70% | ||
| Change in Net Operating Assets | -57.14% | -283.66% | -110.05% | ||
| Cash from Operations | -27.24% | -38.67% | -19.08% | ||
| Capital Expenditure | 17.79% | 2.06% | -86.36% | ||
| Sale of Property, Plant, and Equipment | -- | -- | -- | ||
| Cash Acquisitions | -- | -- | -- | ||
| Divestitures | -- | -- | -- | ||
| Other Investing Activities | -483.82% | -45.29% | 28.33% | ||
| Cash from Investing | -494.32% | -47.39% | 26.85% | ||
| Total Debt Issued | -- | -- | -- | ||
| Total Debt Repaid | -- | -- | -- | ||
| Issuance of Common Stock | -- | 679,520.00% | 296.92% | ||
| Repurchase of Common Stock | -- | -- | -- | ||
| Issuance of Preferred Stock | -- | -- | -- | ||
| Repurchase of Preferred Stock | -- | -- | -- | ||
| Total Dividends Paid | -- | -- | -- | ||
| Other Financing Activities | -- | -336.87% | 44.89% | ||
| Cash from Financing | -- | 72,225.43% | 57.21% | ||
| Foreign Exchange rate Adjustments | -- | -- | -- | ||
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
| Net Change in Cash | -656.41% | 1,482.88% | 24.01% | ||